413 related articles for article (PubMed ID: 9780005)
21. Identification of phosphorylated proteins associated with the fibroblast growth factor receptor type I during early Xenopus development.
Ryan PJ; Paterno GD; Gillespie LL
Biochem Biophys Res Commun; 1998 Mar; 244(3):763-7. PubMed ID: 9535739
[TBL] [Abstract][Full Text] [Related]
22. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.
Noguchi T; Matozaki T; Horita K; Fujioka Y; Kasuga M
Mol Cell Biol; 1994 Oct; 14(10):6674-82. PubMed ID: 7935386
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of insulin signaling components in streptozotocin-treated rats.
Bonini JA; Colca J; Hofmann C
Biochem Biophys Res Commun; 1995 Jul; 212(3):933-8. PubMed ID: 7626133
[TBL] [Abstract][Full Text] [Related]
24. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I).
Hansson A; Hehenberger K; Thorén M
Cell Biochem Funct; 1996 Jun; 14(2):121-9. PubMed ID: 8640952
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
26. Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin's anti-mitogenic activity.
McGuire TF; Xu XQ; Corey SJ; Romero GG; Sebti SM
Biochem Biophys Res Commun; 1994 Oct; 204(1):399-406. PubMed ID: 7524501
[TBL] [Abstract][Full Text] [Related]
27. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.
Stacey DW; Roudebush M; Day R; Mosser SD; Gibbs JB; Feig LA
Oncogene; 1991 Dec; 6(12):2297-304. PubMed ID: 1766676
[TBL] [Abstract][Full Text] [Related]
28. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
29. Interactive roles of Ras, insulin receptor substrate-1, and proteins with Src homology-2 domains in insulin signaling in Xenopus oocytes.
Chuang LM; Hausdorff SF; Myers MG; White MF; Birnbaum MJ; Kahn CR
J Biol Chem; 1994 Nov; 269(44):27645-9. PubMed ID: 7961682
[TBL] [Abstract][Full Text] [Related]
30. Paradoxical biological effects of overexpressed insulin-like growth factor-1 receptors in Chinese hamster ovary cells.
Kato H; Faria TN; Stannard B; Levy-Toledano R; Taylor SI; Roberts CT; LeRoith D
J Cell Physiol; 1993 Jul; 156(1):145-52. PubMed ID: 7686165
[TBL] [Abstract][Full Text] [Related]
31. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
Tanaka S; Ito T; Wands JR
J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
[TBL] [Abstract][Full Text] [Related]
32. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
Myers MG; Sun XJ; Cheatham B; Jachna BR; Glasheen EM; Backer JM; White MF
Endocrinology; 1993 Apr; 132(4):1421-30. PubMed ID: 8384986
[TBL] [Abstract][Full Text] [Related]
33. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells.
Smith-Hall J; Pons S; Patti ME; Burks DJ; Yenush L; Sun XJ; Kahn CR; White MF
Biochemistry; 1997 Jul; 36(27):8304-10. PubMed ID: 9204876
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
[TBL] [Abstract][Full Text] [Related]
35. Modulation of insulin-stimulated glycogen synthesis by Src Homology Phosphatase 2.
Ouwens DM; van der Zon GC; Maassen JA
Mol Cell Endocrinol; 2001 Apr; 175(1-2):131-40. PubMed ID: 11325523
[TBL] [Abstract][Full Text] [Related]
36. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
Mooney RA; Kulas DT; Bleyle LA; Novak JS
Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
Cengel KA; Kason RE; Freund GG
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
[TBL] [Abstract][Full Text] [Related]
38. SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates.
Maegawa H; Kashiwagi A; Fujita T; Ugi S; Hasegawa M; Obata T; Nishio Y; Kojima H; Hidaka H; Kikkawa R
Biochem Biophys Res Commun; 1996 Nov; 228(1):122-7. PubMed ID: 8912646
[TBL] [Abstract][Full Text] [Related]
39. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
[TBL] [Abstract][Full Text] [Related]
40. Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes.
Tanaka S; Mohr L; Schmidt EV; Sugimachi K; Wands JR
Hepatology; 1997 Sep; 26(3):598-604. PubMed ID: 9303488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]